recent publications

• academic article

  • Dasgupta, A., Steinhubl, S. R., Bhatt, D. L., Berger, P. B., Shao, M. Y., Mak, K. H., Fox, K. A. A., Montalescot, G., Weber, M. A., Haffner, S. M., Dimas, A. P., Steg, P. G., et al. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial) American Journal of Cardiology  2009 103:1359-1363  DOI:10.1016/j.amjcard.2009.01.342  PMID:19427428
  • Topol, C. E., Califf, R. M., Simes, R. J., Van de Werf, F., Diaz, R., Paolasso, E., Aylward, P. E., Keech, A., Klein, W., Piegas, L., Tomov, I., Armstrong, P. W., et al. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial Lancet  2000 355:337-345  PMID:10665552